Achieve Life Sciences Inc (NQ: ACHV )
11.62
USD
+0.20
(+1.75%)
Official Closing Price
Updated: 6:13 PM EST, Mar 1, 2021
Add to My Watchlist
Press releases about Achieve Life Sciences Inc
Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
March 13, 2020
From PR Newswire
From PR Newswire
From PR Newswire
From PR Newswire
From PR Newswire
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
December 19, 2019
From PR Newswire
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
December 17, 2019
From PR Newswire
From PR Newswire
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
November 06, 2019
From PR Newswire
Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019
October 31, 2019
From PR Newswire
Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference
October 24, 2019
From PR Newswire
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study
September 30, 2019
From PR Newswire
Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
September 13, 2019
From PR Newswire
From PR Newswire
From PR Newswire
/C O R R E C T I O N -- Achieve Life Sciences, Inc./
August 08, 2019
From PR Newswire
Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
August 08, 2019
From PR Newswire
Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
July 30, 2019
From PR Newswire
From PR Newswire
From PR Newswire
From PR Newswire
Achieve Receives $4.2 Million from Exercise of Warrants
June 03, 2019
From PR Newswire
From PR Newswire
Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
May 15, 2019
From PR Newswire
From PR Newswire
Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
April 23, 2019
From PR Newswire
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
April 02, 2019
From PR Newswire
From PR Newswire
Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019
March 17, 2019
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.